Spruce Biosciences, Inc.(SPRB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SPRB Spruce Biosciences, Inc.

Pre-Mkt 08-31 09:15:44 EDT

60.78

-2.52

-3.98%

盘前62.00

+1.22+2.01%

09:12 EDT

High62.98	Low59.90	Vol39.96K
Open62.12	D1 Closing63.30	Amplitude4.87%
Mkt Cap174.68M	Tradable Cap138.97M	Total Shares2.87M
T/O2.44M	T/O Rate1.75%	Tradable Shares2.29M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SPRB","market":"US","secType":"STK","nameCN":"Spruce Biosciences, Inc.","latestPrice":60.78,"timestamp":1787947200000,"preClose":63.3,"halted":0,"volume":39961,"hourTrading":{"tag":"盘前","latestPrice":62,"preClose":60.78,"latestTime":"09:12 EDT","volume":132,"amount":8059.98006,"timestamp":1788181961935,"change":1.22,"changeRate":0.020072,"amplitude":0.052155},"delay":0,"changeRate":-0.0398104265402843,"floatShares":2286500,"shares":2874013,"eps":-38.43,"marketStatus":"Pre-Mkt","change":-2.52,"latestTime":"08-31 09:15:44 EDT","open":62.115,"high":62.98,"low":59.895,"amount":2439166.132026,"amplitude":0.048736,"askPrice":66.99,"askSize":20,"bidPrice":56.55,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-38.43,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788183000000},"marketStatusCode":1,"adr":0,"listingDate":1602216000000,"exchange":"NASDAQ","adjPreClose":60.78,"preHourTrading":{"tag":"盘前","latestPrice":62,"preClose":60.78,"latestTime":"09:12 EDT","volume":132,"amount":8059.98006,"timestamp":1788181961935,"change":1.22,"changeRate":0.020072,"amplitude":0.052155},"postHourTrading":{"tag":"盘后","latestPrice":60.78,"preClose":60.78,"latestTime":"19:32 EDT","volume":202,"amount":12236.47,"timestamp":1787959938108,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.38388457115945473,"impliedVol":0.883,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/SPRB","defaultTab":"news","newsList":[{"id":"2662719199","title":"Spruce Biosciences announces launch of MPS3BStudy.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2662719199","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662719199?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:15","pubTimestamp":1787746555,"startTime":"0","endTime":"0","summary":"Spruce Biosciences (SPRB) announced the launch of MPS3BStudy.com. The website enables families and caregivers to learn about, and register their in...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/spruce-biosciences-announces-launch-of-mps3bstudy-com-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/spruce-biosciences-announces-launch-of-mps3bstudy-com-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SPRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662716706","title":"Spruce Biosciences, - Biosciences Launches Mps3bstudy.com for Mps Iiib Families and Caregivers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662716706","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662716706?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:05","pubTimestamp":1787745956,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0G9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SPRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662716704","title":"Spruce Biosciences, - Ta-Ert Eap and Transform Study Expected to Initiate in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662716704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662716704?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:05","pubTimestamp":1787745956,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N0G9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662162887","title":"Spruce Biosciences Launches Site for Planned TA-ERT Sanfilippo B Confirmatory Trial in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662162887","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662162887?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:02","pubTimestamp":1787745773,"startTime":"0","endTime":"0","summary":"Spruce Biosciences launches site for planned TA-ERT Sanfilippo B confirmatory trial in Q4 2026Spruce Biosciences launched MPS3BStudy.com to register interest for planned U.S. access and trial programs","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL5mRrrG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662734853","title":"Oppenheimer Sticks to Its Buy Rating for Spruce Biosciences (SPRB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662734853","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662734853?lang=en_us&edition=fundamental","pubTime":"2026-08-25 19:55","pubTimestamp":1787658927,"startTime":"0","endTime":"0","summary":"In a report released today, Leland Gershell from Oppenheimer reiterated a Buy rating on Spruce Biosciences, with a price target of $230.00. Accordi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-its-buy-rating-for-spruce-biosciences-sprb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-sticks-to-its-buy-rating-for-spruce-biosciences-sprb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","SPRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661763942","title":"Spruce Biosciences Targets Q4 2026 BLA Filing for TA-ERT in Sanfilippo Syndrome Type B After FDA Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2661763942","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661763942?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:01","pubTimestamp":1787572879,"startTime":"0","endTime":"0","summary":"Spruce Biosciences targets Q4 2026 BLA filing for TA-ERT in Sanfilippo syndrome type B after FDA meetingsSpruce Biosciences reported positive pre-BLA meetings with the FDA for TA-ERT in Sanfilippo syn","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL3pFRlT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661763302","title":"Spruce Biosciences, - Co and FDA Aligned on Confirmatory Study Design; Initiation May Occur During Bla Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2661763302","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661763302?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAB0Z7Y7:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661327682","title":"Spruce Biosciences Announces Positive Pre-Bla Meetings with FDA and Confirms Bla Submission for Ta-Ert on Track for Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2661327682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661327682?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAB0Z7Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276800","title":"Spruce Biosciences, - FDA and Spruce Aligned on Content and Format of Planned Bla","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276800","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276800?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAB0Z7Y7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SPRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276358","title":"Spruce Biosciences, - Pursuing Accelerated Approval Pathway Based on Reduction of Csf Hs-Nre","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276358","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276358?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAB0Z7Y7:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SPRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276356","title":"Spruce Biosciences, - FDA Finds Spruce's Comparability Strategies Reasonable Following Technology Transfer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276356","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276356?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:00","pubTimestamp":1787572800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAB0Z7Y7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661293391","title":"Analysts Offer Insights on Healthcare Companies: Brookdale Senior Living (BKD) and Spruce Biosciences (SPRB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661293391","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661293391?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:50","pubTimestamp":1787316622,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Brookdale Senior Living (BKD) and Spruce Biosciences...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-brookdale-senior-living-bkd-and-spruce-biosciences-sprb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-brookdale-senior-living-bkd-and-spruce-biosciences-sprb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1499592464.USD","LU0128526141.USD","LU2190626999.HKD","BK4585","SPRB","XLV","BK4139","LABU","BKD","LU0029874061.USD","XBI","BK4137","BK4588","HCSG","BK4185","LU0842063009.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659990044","title":"Longeveron Q2 Net Loss Widens on Higher Legal, Clinical Trial Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2659990044","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659990044?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:22","pubTimestamp":1786566165,"startTime":"0","endTime":"0","summary":"Longeveron Q2 net loss widens on higher legal, clinical trial costsOverviewUS biotech firm's Q2 revenue fell 10% yr/yr, mainly due to lower contract manufacturing incomeNet loss for Q2 widened 22% yr/","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N44911Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","SPRB","APRE","OLMA","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658905027","title":"Spruce Biosciences Q2 FY26 Net Loss Widens to $16.23 Million; R&D Expenses Rise to $12.16 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658905027","media":"Reuters","labels":["executive","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658905027?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:08","pubTimestamp":1786547305,"startTime":"0","endTime":"0","summary":"Spruce Biosciences Q2 FY26 net loss widens to $16.23 million; R&D expenses rise to $12.16 millionSpruce Biosciences posted a Q2 net loss of USD 16.2 million, or USD 6.68 per share.Cash and cash equiva","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL4MSR0w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903161","title":"Spruce Biosciences, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903161","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658903161?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:13","pubTimestamp":1786544037,"startTime":"0","endTime":"0","summary":"Spruce Biosciences, Inc. reports results for the quarter ended June 30 - Earnings SummarySpruce Biosciences, Inc.SPRB.OQreported a quarterly adjusted loss of $6.68 per share for the quarter ended June","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4491IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658704239","title":"Spruce Biosciences Q2 Net Loss Widens on Higher Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2658704239","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658704239?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:10","pubTimestamp":1786540211,"startTime":"0","endTime":"0","summary":"Spruce Biosciences Q2 net loss widens on higher expensesOverviewUS biopharmaceutical firm's Q2 net loss widened as operating expenses increased to advance TA-ERTCompany expects TA-ERT BLA submission a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4490JV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRX","TARA","BK4080","BK4231","BK4007","ELOX","SPRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658197012","title":"Spruce Biosciences - Bla Submission for Ta-Ert for Mps Iiib Anticipated in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658197012","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658197012?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:00","pubTimestamp":1786539604,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA6HVJZF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658970950","title":"Spruce Biosciences Q2 EPS USD -6.68","url":"https://stock-news.laohu8.com/highlight/detail?id=2658970950","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658970950?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:00","pubTimestamp":1786539602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLX2C8MS1:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SPRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658669970","title":"Spruce Biosciences Q2 Operating Expenses USD 16.512 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658669970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658669970?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:00","pubTimestamp":1786539602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nPLX2C8MS1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SPRB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972275","title":"Cure Sanfilippo Foundation, National MPS Society Invest $5.5 Million in Spruce Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972275","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972275?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:16","pubTimestamp":1786537011,"startTime":"0","endTime":"0","summary":"Cure Sanfilippo Foundation, National MPS Society invest $5.5 million in Spruce BiosciencesCure Sanfilippo Foundation, National MPS Society to invest a combined USD 5.5 million in Spruce Biosciences.Pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLbp0GsM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sprucebiosciences.com","stockEarnings":[{"period":"1week","weight":0.1784},{"period":"1month","weight":0.4663},{"period":"3month","weight":0.1855},{"period":"6month","weight":0.1063},{"period":"1year","weight":449.2222},{"period":"ytd","weight":-0.3023}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0547},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1215},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.1282}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovary syndrome, which is in Phase 2 clinical trial. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses; and collaboration and license agreement with Kaken Pharmaceutical Co. Ltd. to develop, manufacture, and commercialize tildacerfont for the treatment of CAH in Japan. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in South San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.190445},{"month":2,"riseRate":0.5,"avgChangeRate":-0.036118},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.209049},{"month":4,"riseRate":0,"avgChangeRate":-0.19428},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.048966},{"month":6,"riseRate":0.5,"avgChangeRate":-0.057688},{"month":7,"riseRate":0.5,"avgChangeRate":0.040059},{"month":8,"riseRate":0.5,"avgChangeRate":0.093631},{"month":9,"riseRate":0.4,"avgChangeRate":-0.136102},{"month":10,"riseRate":0.4,"avgChangeRate":2.105377},{"month":11,"riseRate":0.5,"avgChangeRate":0.001192},{"month":12,"riseRate":0.333333,"avgChangeRate":0.217863}],"exchange":"NASDAQ","name":"Spruce Biosciences, Inc.","nameEN":"Spruce Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spruce Biosciences, Inc.(SPRB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Spruce Biosciences, Inc.(SPRB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Spruce Biosciences, Inc.,SPRB,Spruce Biosciences, Inc.股票,Spruce Biosciences, Inc.股票老虎,Spruce Biosciences, Inc.股票老虎国际,Spruce Biosciences, Inc.行情,Spruce Biosciences, Inc.股票行情,Spruce Biosciences, Inc.股价,Spruce Biosciences, Inc.股市,Spruce Biosciences, Inc.股票价格,Spruce Biosciences, Inc.股票交易,Spruce Biosciences, Inc.股票购买,Spruce Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spruce Biosciences, Inc.(SPRB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Spruce Biosciences, Inc.(SPRB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}